OriginBio Medical Laboratory is a specialized institution focused on the field of precision medicine, centered around high-performance genetic testing technology. Deeply aligned with the integrated prevention and treatment requirements of the National Health Commission, it leverages cutting-edge technology and multidisciplinary integration to develop three core solutions: rapid pathogen detection, precision medication guidance for chronic diseases through genetic testing, and early cancer screening and companion diagnostics. These solutions provide scientific evidence for clinical diagnosis and treatment, fully promoting the development of new models of personalized healthcare.

The laboratory has built its core business around precision medicine to effectively address clinical challenges. Firstly, the rapid pathogen detection service uses molecular biology techniques to accurately identify pathogens, significantly reducing the testing period to 48 hours, providing critical support for public health emergencies and aiding in the swift interruption of infection transmission. Secondly, the precision medication guidance service for chronic diseases integrates proteomics and metabolomics to deeply analyze gene variations related to drug metabolism, offering tailored medication plans for patients with chronic conditions such as hypertension and diabetes, effectively lowering the risk of adverse drug reactions and markedly improving treatment outcomes. Thirdly, the early cancer screening and companion diagnostics service utilizes gene sequencing and liquid biopsy technologies to non-invasively monitor circulating tumor DNA (ctDNA), achieving a detection sensitivity of 92%, covering early screening and targeted therapy guidance for digestive tract cancers like esophageal, gastric, and colorectal cancers, ensuring early detection and intervention. Additionally, the laboratory actively prepares for forward-looking projects, conducting evaluations of vaccine efficacy such as rabies virus neutralizing antibody and HPV neutralizing antibody tests, using quantitative antibody analysis to verify immune effectiveness, providing scientific support for optimizing vaccination protocols and enhancing protection, thereby reducing disease risks.

Precision, efficiency, and innovation are the core competencies of the laboratory. Technically, it possesses high-precision detection capabilities for pathogens, genetic mutations, and tumor markers, with rigorous control throughout the entire process to ensure accurate and reliable results. In terms of service, by optimizing processes and technologies, it significantly reduces testing times, quickly generates reports, and efficiently responds to urgent needs from clinics and patients. On the innovation front, it continuously introduces new technologies and methods, advancing projects such as vaccine efficacy evaluations, constantly optimizing its service system, and providing cutting-edge solutions for the healthcare sector.

Currently, the laboratory has established the OriginBio Medical Testing Center in Zhengzhou and a Precision Medicine Center in Shenzhen, building a cross-regional service network. Looking ahead, the laboratory will continue to lead with technological innovation, deepen its practice in precision medicine, and contribute professional strength to improve the health of the entire population.